Compass Therapeutics, Inc. · NASDAQ:CMPX
BVF PARTNERS L P/IL's stake in Compass Therapeutics, Inc. fell to 4.30% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
BVF PARTNERS L P/IL's stake in Compass Therapeutics, Inc. fell to 4.30%, 7,764,842 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 7,764,842
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.30% | 4,142,020 |
| BVF I GP LLC | 2.30% | 4,142,020 |
| BIOTECHNOLOGY VALUE FUND II LP | 1.70% | 3,028,951 |
| BVF II GP LLC | 1.70% | 3,028,951 |
| Biotechnology Value Trading Fund OS LP | 0.30% | 476,311 |
| BVF Partners OS Ltd. | 0.30% | 476,311 |
| BVF GP HOLDINGS LLC | 4.00% | 7,170,971 |
| BVF PARTNERS L P/IL | 4.30% | 7,764,842 |
| BVF INC/IL | 4.30% | 7,764,842 |
| LAMPERT MARK N | 4.30% | 7,764,842 |
Source
Related
- Compass Therapeutics, Inc.
- Bvf Partners L P
- Compass Therapeutics, Inc. shareholders
- Schedule 13G · Bvf Partners L P · Oct 29, 2025
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4/A · Lerner Neil · Apr 30, 2026